Related Experiment Videos
Generation of effective antitumor vaccines using photodynamic therapy
Sandra O Gollnick1, Lurine Vaughan, Barbara W Henderson
1PDT Center, Roswell Park Cancer Institute, Buffalo, New York 14263, USA. Sandra.Gollnick@roswellpark.org
Abstract:
Preclinical studies have shown that photodynamic therapy (PDT) of tumors augments the host antitumor immune response. However, the role of the PDT effect on tumor cells as opposed to the host tissues has not been determined. To test the contribution of the direct effects of PDT on tumor cells to the enhanced antitumor response by the host, we examined the immunogenicity of PDT-generated murine tumor cell lysates in a preclinical vaccine model. We found that the PDT-generated tumor cell lysates were potent vaccines and that PDT-generated vaccines are more effective than other modes of creating whole tumor vaccines, i.e., UV or ionizing irradiation, and unlike other traditional vaccines, PDT vaccines do not require coadministration of an adjuvant to be effective. PDT vaccines are tumor specific and appear to induce a cytotoxic T-cell response. We have demonstrated that although both UV and PDT-generated tumor cell lysates are able to induce phenotypic DC maturation, only PDT-generated lysates are able to activate DCs to express IL-12, which is critical to the development of a cellular immune response. Our results show that PDT effects on tumor cells alone are sufficient to generate an antitumor immune response, indicating that the direct tumor effects of PDT play an important role in enhancing that host antitumor immune response. These studies also suggest that in addition to the role of PDT as a therapeutic modality, PDT-generated vaccines may have clinical potential as an adjuvant therapy.
Insights
Photodynamic therapy (PDT) of tumors generates potent vaccines from tumor cell lysates. These PDT-generated vaccines enhance antitumor immune responses without needing adjuvants, showing direct tumor cell effects are key.
Area of Science:
- Immunology
- Oncology
- Photodynamic Therapy
Background:
- Preclinical studies indicate photodynamic therapy (PDT) enhances host antitumor immune responses.
- The specific contribution of PDT's direct effects on tumor cells versus host tissues remains unclear.
- Understanding these direct effects is crucial for optimizing PDT as a cancer therapy and vaccine.
Purpose of the Study:
- To determine the contribution of direct photodynamic therapy (PDT) effects on tumor cells to host-mediated antitumor responses.
- To evaluate the immunogenicity of PDT-generated murine tumor cell lysates as a preclinical vaccine model.
- To compare the efficacy of PDT-generated vaccines with other whole tumor vaccine generation methods.
Main Methods:
- Generated tumor cell lysates using photodynamic therapy (PDT), UV irradiation, and ionizing irradiation.
- Examined the immunogenicity of these lysates in a preclinical vaccine model.
- Assessed dendritic cell (DC) maturation and cytokine expression (IL-12) following exposure to different lysates.
Main Results:
- Photodynamic therapy (PDT)-generated tumor cell lysates demonstrated potent vaccine capabilities.
- PDT vaccines were more effective than UV or ionizing irradiation-generated vaccines and did not require adjuvants.
- PDT-generated lysates uniquely activated dendritic cells (DCs) to express IL-12, crucial for cellular immune responses.
Conclusions:
- Direct effects of photodynamic therapy (PDT) on tumor cells are sufficient to generate a significant antitumor immune response.
- PDT-generated vaccines show tumor specificity and induce a cytotoxic T-cell response.
- PDT-generated vaccines hold potential as an adjuvant therapy, in addition to PDT's therapeutic role.